Purple Biotech Appoints New CFO
Ticker: PPBT · Form: 6-K · Filed: May 12, 2025 · CIK: 1614744
Sentiment: neutral
Topics: personnel-change, cfo-appointment
TL;DR
Purple Biotech just hired a new CFO, Shai Lankry.
AI Summary
Purple Biotech Ltd. announced on May 12, 2025, the appointment of Shai Lankry as its new Chief Financial Officer. This appointment is detailed in a press release filed as Exhibit 99.1 with the SEC.
Why It Matters
A new CFO can signal strategic shifts or financial restructuring within the company, impacting investor confidence and future financial performance.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a personnel change and does not contain significant financial or operational risks.
Key Players & Entities
- Purple Biotech Ltd. (company) — The company making the announcement.
- Shai Lankry (person) — Newly appointed Chief Financial Officer.
- May 12, 2025 (date) — Date of the press release and filing.
- Exhibit 99.1 (document) — The press release attached to the filing.
FAQ
Who is the new Chief Financial Officer of Purple Biotech Ltd.?
Shai Lankry has been appointed as the new Chief Financial Officer of Purple Biotech Ltd.
When was this appointment announced?
The appointment was announced on May 12, 2025.
What is the form type of this SEC filing?
The form type is a 6-K, Report of Foreign Private Issuer.
What is the company's principal executive office address?
The company's principal executive offices are located at 4 Oppenheimer Street, Science Park, Rehovot 7670104, Israel.
What was Purple Biotech Ltd. formerly known as?
Purple Biotech Ltd. was formerly known as Kitov Pharma Ltd. and Kitov Pharmaceuticals Holdings Ltd.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 12, 2025 by Shai Lankry regarding PURPLE BIOTECH LTD. (PPBT).